Table 3.
|
Treatment A |
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Women |
Men |
||||||||||||||||||||||
|
Control |
SC |
CC |
NC |
Control |
SC |
CC |
NC |
||||||||||||||||
Mdna | BOb | pc | Mdn | BO | p | Mdn | BO | p | Mdn | BO | p | Mdn | BO | p | Mdn | BO | p | Mdn | BO | p | Mdn | BO | p | |
Treatment B | ||||||||||||||||||||||||
Control | ||||||||||||||||||||||||
PG | −0.4 | 7.0 | 0.87 | −0.2 | 3.1 | 0.76 | −0.3 | 5.5 | .85 | 0.005 | 0.97 | 0.49 | −0.4 | 22.6 | 0.96 | −0.4 | 20.2 | 0.95 | ||||||
GRE | −0.2 | 3.2 | 0.76 | 0.09 | 0.55 | 0.35 | −0.1 | 2.4 | 0.70 | 0.2 | 0.27 | 0.22 | −0.2 | 4.3 | 0.81 | −0.1 | 2.3 | 0.69 | ||||||
CESD | −0.3 | 2.3 | 0.70 | −0.1 | 1.5 | 0.60 | −0.7 | 7.9 | 0.89 | 0.3 | 0.31 | 0.24 | 0.4 | 0.18 | 0.16 | −0.05 | 1.2 | 0.54 | ||||||
SC | ||||||||||||||||||||||||
PG | 0.4 | 0.15 | 0.13 | 0.1 | 0.54 | 0.35 | 0.05 | 0.79 | 0.44 | −0.005 | 1.0 | 0.51 | −0.4 | 18.7 | 0.95 | −0.4 | 19.2 | 0.95 | ||||||
GRE | 0.2 | 0.32 | 0.24 | 0.3 | 0.16 | 0.14 | 0.05 | 0.74 | 0.43 | −0.2 | 3.5 | 0.78 | −0.4 | 17.9 | 0.95 | −0.3 | 8.0 | 0.89 | ||||||
CESD | 0.3 | 0.43 | 0.30 | 0.1 | 0.69 | 0.41 | −0.4 | 3.0 | 0.75 | −0.3 | 3.2 | 0.76 | 0.1 | 0.67 | 0.40 | −0.4 | 3.9 | 0.80 | ||||||
CC | ||||||||||||||||||||||||
PG | 0.2 | 0.32 | 0.24 | −0.1 | 1.9 | 0.65 | −0.08 | 1.5 | 0.61 | 0.4 | 0.04 | 0.04 | 0.4 | 0.05 | 0.05 | 0.008 | 0.95 | 0.49 | ||||||
GRE | 0.09 | 0.54 | 0.65 | −0.3 | 6.1 | 0.86 | −0.2 | 4.3 | 0.81 | 0.2 | 0.23 | 0.19 | 0.4 | 0.05 | 0.05 | 0.1 | 0.50 | 0.33 | ||||||
CESD | 0.1 | 0.66 | 0.40 | −0.1 | 1.4 | 0.59 | −0.5 | 4.8 | 0.83 | −0.4 | 5.3 | 0.84 | −0.1 | 1.5 | 0.60 | −0.5 | 6.6 | 0.87 | ||||||
NC | ||||||||||||||||||||||||
PG | 0.3 | 0.18 | 0.15 | −0.05 | 1.3 | 0.56 | 0.08 | 0.64 | 0.39 | 0.4 | 0.05 | 0.05 | 0.4 | 0.05 | 0.05 | −0.008 | 1.0 | 0.51 | ||||||
GRE | 0.1 | 0.43 | 0.30 | −0.05 | 1.3 | 0.57 | 0.2 | 0.23 | 0.19 | 0.1 | 0.45 | 0.31 | 0.3 | 0.14 | 0.11 | −0.1 | 2.0 | 0.67 | ||||||
CESD | 0.7 | 0.14 | 0.11 | 0.4 | 0.33 | 0.25 | 0.5 | 0.20 | 0.17 | 0.05 | 0.85 | 0.46 | 0.4 | 0.25 | 0.20 | 0.5 | 0.15 | 0.13 |
Mdn, median estimate of the difference in recovery slopes across the postbaseline measurement waves (effect size).
BO, Bayesian odds ratio. Using Jeffreys criterion,56 evidence is substantial if BO ≥ 3.2 and strong if BO ≥ 10.
p, Probability that the slope of recovery due to treatment A is steeper (faster) than the slope of recovery to treatment B.